Boston Scientific Corporation

About Boston Scientific Corporation

Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Their mission is to advance science for life, helping patients experience more in their daily lives through cutting-edge therapies and treatments.

Products & Services

Critical Care Products:Solutions for critical care medical needs.

Electrophysiology Products:Devices and therapies for heart rhythm disorders.

Female Pelvic Medicine Products:Treatments for female pelvic health issues.

Gastroenterology Products:Solutions for digestive system conditions.

Gastrointestinal Surgery Products:Tools and therapies for GI surgical procedures.

Gynecology Products:Medical solutions for gynecological health.

Interventional Cardiology Products:Devices for heart disease interventions, such as stents.

Otolaryngology Products:Devices for ear, nose, and throat conditions.

Pain Management Products:Therapies like spinal cord stimulation for chronic pain.

Heart and Vascular Therapies:Includes pacemakers, defibrillators, and treatments for conditions like atrial fibrillation and coronary artery disease.

Cancer Treatment Devices:Therapies for colorectal, liver, and prostate cancer.

Men's Health Solutions:Treatments for erectile dysfunction, kidney stones, and urinary incontinence.

Women's Health Solutions:Solutions for bladder leakage and pelvic organ prolapse.

Neurological Condition Devices:Deep Brain Stimulation for neurological disorders.

Specialties

Critical Care Electrophysiology Female Pelvic Medicine Gastroenterology Gastrointestinal Surgery Gynecology Heart Failure Interventional Cardiology Interventional Radiology Neurological Surgery Otolaryngology Pain Management Pulmonology Structural Heart Valve Urology Vascular Surgery Cancer Therapies Heart and Vascular Treatments Men's and Women's Health

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 1500000000 MR: - FA: €1.5 billion FAN: 1500000000	D: 2025-02-26 FD: 2025-02-26	-
2	RT: Debt T: - FT: Debt	A: 1500000000 MR: - FA: €1.5 billion FAN: 1500000000	D: 2025-02-21 FD: 2025-02-21	3 investors
3	RT: Debt T: - FT: Debt	A: 2000000000 MR: - FA: €2,000,000,000 FAN: 2000000000	D: 2024-02-27 FD: 2024-02-27	-

Debt Latest

2025-02-26

$1.5B

Debt 2025-02-21

$1.5B

Debt 2024-02-27

$2.0B

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Mike

M

Mike Mahoney

Chairman and CEO

E

Ellen

E

Ellen Frazier

G

Greg

G

Greg Fritz

View 3 more team members with Pro

Unlock Full Team Directory

Recent News